However, when β-catenin expression was suppressed using an inhibitor XAV 939, cardiac hypertrophy associated transcription factor NFATc3 and hypertrophy marker BNP were also downregulated (Figure 1B). The gene discussed is NPPB; the disease is cardiac hypertrophy.